Search Results - "Kurtz, David Matthew"

Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC) by Isbell, James M., Goldstein, Jordan Scott, Hamilton, Emily G., Liu, Si-Yang, Eichholz, Jordan, Buonocore, Darren J., Rusch, Valerie W., Bott, Matthew, Molena, Daniela, Rocco, Gaetano, Yang, Soo-Ryum, Rudin, Charles M., Jones, David R, Roff, Alanna, Schultz, Andre, Chabon, Jake J., Kurtz, David Matthew, Alizadeh, Ash A., Li, Bob T., Diehn, Maximilian

“…8078 Background: Translation of ctDNA MRD in NSCLC has been hampered by suboptimal sensitivity of 1st-generation assays. Here, we explore how improvements in…”
Get full text

Leveraging phased variants for personalized minimal residual disease detection in localized non-small cell lung cancer by Kurtz, David Matthew, Chabon, Jacob J., Sworder, Brian, Co Ting Keh, Lyron, Soo, Joanne, Alig, Stefan, Schultz, Andre, Garofalo, Andrea, Hamilton, Emily G., Chen, Binbin, Olsen, Mari, Moding, Everett James, Liu, Chih Long, Alizadeh, Ash A., Diehn, Maximilian

“…Abstract only 8518 Background: Detection of circulating tumor DNA (ctDNA) has prognostic value in lung cancer and could facilitate minimal residual disease…”
Get full text

Phased variants improve DLBCL minimal residual disease detection at the end of therapy by Kurtz, David Matthew, Chabon, Jacob J., Soo, Joanne, Co Ting Keh, Lyron, Alig, Stefan, Schultz, Andre, Jin, Michael C., Scherer, Florian, Craig, Alexander F.M., Liu, Chih Long, Duehrsen, Ulrich, Huettmann, Andreas, Casasnovas, René-Olivier, Westin, Jason, Roschewski, Mark J., Wilson, Wyndham Hopkins, Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A.

“…Abstract only 7565 Background: Detection of circulating tumor DNA (ctDNA) has prognostic value in diverse tumors, including DLBCL. Despite uses for assessing…”
Get full text

Post-transplant head and neck cancers: A prospective analysis of clinical factors for risk stratification by Soo, Joanne, Schroers-Martin, Joseph, Garofalo, Andrea, Kurtz, David Matthew, D'Emilio, Nathan, Grimm, David Robert, Luikart, Helen, Diehn, Maximilian, Sunwoo, John B., Khush, Kiran K, Alizadeh, Ash A.

“…Abstract only…”
Get full text

Changes in circulating tumor DNA levels are associated with treatment response and progression-free survival in relapse/refractory DLBCL subjects by Lovejoy, Alexander F., Lin, Hai, Tabari, Ehsan, Saelee, Seng Lor, Kurtz, David Matthew, Vitazka, Patrik, Morschhauser, Franck, Chu, Yu-Waye, Szafer-Glusman, Edith, Venstrom, Jeffrey Michael, Luong, Khai, Klass, Daniel M.

“…Abstract only 7546 Background: Detection of an initial molecular response to therapy in DLBCL could help differentiate patients who will relapse (30-40% of…”
Get full text

KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer by Binkley, Michael S, Jeon, Young-Jun, Nesselbush, Monica, Moding, Everett J, Nabet, Barzin, Almanza, Diego S, Yoo, Christopher, Kurtz, David Matthew, Owen, Susie Grant, Backhus, Leah Monique, Berry, Mark F., Shrager, Joseph B, Ramchandran, Kavitha, Padda, Sukhmani Kaur, Das, Millie, Neal, Joel W., Wakelee, Heather A., Alizadeh, Ash A., Loo, Billy W., Diehn, Maximilian

“…Abstract only 9012 Background: Tumor genotyping in localized non-small cell lung cancer (NSCLC) is not broadly performed due to lack of actionable associations…”
Get full text

Elucidation of distinct mutational patterns between diffuse large B cell lymphoma subtypes utilizing circulating tumor DNA by Soo, Joanne, Kurtz, David Matthew, Scherer, Florian, Craig, Alexander F.M., Jin, Michael C., Westin, Jason R., Rossi, Davide, Gaidano, Gianluca, Advani, Ranjana H., Diehn, Maximilian, Alizadeh, Ash A.

“…Abstract only 7538 Background: Patients with diffuse large B cell lymphoma (DLBCL) exhibit significant differences in clinical outcome based on cell-of-origin…”
Get full text

Early detection of post-transplant lymphoproliferative disorder using circulating tumor DNA by Soo, Joanne, Schroers-Martin, Joseph, Garofalo, Andrea, Kurtz, David Matthew, D'Emilio, Nathan, Grimm, David Robert, Luikart, Helen, Van De Rijn, Matt, Diehn, Maximilian, Khush, Kiran K, Alizadeh, Ash A.

“…Abstract only…”
Get full text

Analysis of circulating tumor DNA in localized lung cancer for detection of molecular residual disease and personalization of adjuvant strategies by Chaudhuri, Aadel, Chabon, Jacob J., Lovejoy, Alexander F., Newman, Aaron M., Stehr, Henning, Azad, Tej D., Carter, Justin N., Merriott, David J., Liu, Chih Long, Kurtz, David Matthew, Dudley, Jonathan C., Padda, Sukhmani Kaur, Shrager, Joseph B, Neal, Joel W., Wakelee, Heather A., Loo, Billy W., Alizadeh, Ash A., Diehn, Maximilian

“…Abstract only 8519 Background: Identifying localized non-small cell lung cancer (NSCLC) patients with residual disease following curative intent therapy is…”
Get full text

Noninvasive detection of clinically relevant copy number alterations in diffuse large B-cell lymphoma by Jin, Michael C., Kurtz, David Matthew, Esfahani, Mohammad Shahrokh, Scherer, Florian, Craig, Alexander F.M., Soo, Joanne, Khodadoust, Michael Siavash, Saganty, Ruth Sharon, Chabon, Jacob J., Schroers-Martin, Joseph, Stehr, Henning, Advani, Ranjana H., Rossi, Davide, Gaidano, Gianluca, Westin, Jason R., Diehn, Maximilian, Alizadeh, Ash A.

“…Abstract only 7507 Background: Somatic copy number alterations (SCNAs) are common and clinically important genomic events in lymphomas. For example, MYC and…”
Get full text

Distinct early response dynamics of circulating tumor DNA and circulating tumor cells during therapy of B-cell NHL by Kurtz, David Matthew, Scherer, Florian, Green, Michael Richard, Khodadoust, Michael Siavash, Klass, Daniel M., Zhou, Li, Krishnan, Rashi, Glover, Cynthia, Liu, Chih Long, Kong, Katherine A, Faham, Malek, Levy, Ronald, Diehn, Maximilian, Alizadeh, Ash A.

“…Abstract only…”
Get full text

Noninvasive molecular subtyping and risk stratification of DLBCL by Scherer, Florian, Kurtz, David Matthew, Newman, Aaron M., Stehr, Henning, Craig, Alexander F.M., Esfahani, Mohammad S, Lovejoy, Alexander F., Chabon, Jacob J., Klass, Daniel M., Liu, Chih Long, Zhou, Li, Glover, Cynthia, Advani, Ranjana H., Maeda, Lauren Shizue, Gupta, Neel K., Levy, Ronald, Ohgami, Robert S., Kunder, Christian, Diehn, Maximilian, Alizadeh, Ash A.

“…Abstract only…”
Get full text

Prediction of therapeutic outcomes in DLBCL from circulating tumor DNA dynamics by Kurtz, David Matthew, Scherer, Florian, Newman, Aaron M., Craig, Alexander F.M., Khodadoust, Michael Siavash, Lovejoy, Alexander F., Klass, Daniel M., Chabon, Jacob J., Glover, Cynthia, Zhou, Li, Liu, Chih Long, Gupta, Neel K., Maeda, Lauren Shizue, Advani, Ranjana H., Levy, Ronald, Diehn, Maximilian, Alizadeh, Ash A.

“…Abstract only…”
Get full text

Inter- and intra-patient heterogeneity of resistance mechanisms to the mutant EGFR selective inhibitor rociletinib by Chabon, Jacob J., Simmons, Andrew, Newman, Aaron M., Lovejoy, Alexander F., Esfahani, Mohammad S, Haringsma, Henry, Kurtz, David Matthew, Stehr, Henning, Scherer, Florian, Durkin, Kathleen A., Otterson, Gregory Alan, Purcell, William T., Camidge, D. Ross, Goldman, Jonathan Wade, Sequist, Lecia V., Piotrowska, Zofia, Wakelee, Heather A., Neal, Joel W., Alizadeh, Ash A., Diehn, Maximilian

“…Abstract only…”
Get full text

Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC by Newman, Aaron M., Lovejoy, Alexander F., Klass, Daniel M., Kurtz, David Matthew, Chabon, Jacob J., Scherer, Florian, Stehr, Henning, Liu, Chih Long, Bratman, Scott Victor, Say, Carmen, Zhou, Li, Carter, Justin N, West, Robert B., Sledge, George W., Shrager, Joseph B, Loo, Billy W., Neal, Joel W., Wakelee, Heather A., Alizadeh, Ash A., Diehn, Maximilian

“…Abstract only…”
Get full text

Noninvasive monitoring of cellular versus acellular tumor DNA from immunoglobulin genes for DLBCL by Kurtz, David Matthew, Green, Michael R, Bratman, Scott Victor, Liu, Chih-Long, Glover, Cynthia, Keane, Colm, Kong, Katie, Faham, Malek, Miklos, David Bernard, Advani, Ranjana H., Levy, Ronald, Hertzberg, Mark S., Gandhi, Maher K, Diehn, Maximilian, Alizadeh, Ash A.

“…Abstract only…”
Get full text

Pre-treatment circulating tumor DNA as a biomarker for disease burden in diffuse large B cell lymphoma (DLBCL) by Scherer, Florian, Kurtz, David Matthew, Green, Michael Richard, Newman, Aaron M., Klass, Daniel M., Zhou, Li, Krishnan, Rashi, Liu, Chih Long, Glover, Cynthia, Ohgami, Robert S., Hicks, Rodney J, Keane, Colm, Kong, Katherine A, Faham, Malek, Hertzberg, Mark S., Gandhi, Maher K, Advani, Ranjana H., Levy, Ronald, Diehn, Maximilian, Alizadeh, Ash A.

“…Abstract only…”
Get full text